ALMR

Investor Moves

Name	Value	Action	Change	Price	Current Price
Cathie WoodARK Invest $337k13k shares BuyQ3 2026 $337k13k shares $22.83 $26.67
Cathie WoodARK Invest $1.9M83.9k shares BuyQ3 2026 $2.2M83.9k shares $22.77 $26.67
Cathie WoodARK Invest $427k18.8k shares BuyQ2 2026 $502k18.8k shares $22.70 $26.67

Trade ALMR

About Alamar Biosciences, Inc.

Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.

CEO: Justin J. McAnear
IPO Date: Apr 17, 2026

Market Data

Volume: 1.7M

Valuation

Market Cap: $180M

Financials

Financial statement snapshot is not available yet.